World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Biopharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as of August 2026.

World Top Biopharmaceutical Companies 2026
World Largest Biopharmaceutical Companies by Market Cap in 2026, World Top Biopharmaceutical Companies by Market Cap in 2026.

  1. Sino Biopharmaceutical

    World Rank (Aug-2026)
    1,827
    Market Cap (Aug-2026)
    12.683 Billion USD
    World Rank (Jan-05-2024)
    2,021
    Market Cap (Jan-05-2024)
    7.944 Billion USD
    World Rank (Jul-30-2023)
    1,899
    Market Cap (Jul-30-2023)
    8.629 Billion USD
    World Rank (Dec-25-2022)
    1,459
    Market Cap (Dec-25-2022)
    10.655 Billion USD
    World Rank (Jan-07-2022)
    1,423
    Market Cap (Jan-07-2022)
    14.15 Billion USD
    Annual Revenue in USD
    4,026 Million USD
    Annual Operating Income in USD
    844 Million USD
    Annual Net Income in USD
    356 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Hong Kong
    Yahoo @ HongKong
    Company Profile
    SINO BIOPHARMACEUTICAL is BioPharmaceutical company with headquarters is in Hong Kong. The products include a variety of biological drugs and chemical drugs, and are in an advantageous position in many potential therapeutic fields such as liver disease, tumor, cardiovascular and cerebrovascular disease, orthopedics, digestive system, anti-infection and respiratory diseases.
    Company Website
    SINO BIOPHARM - Bio-Pharmaceutical Company
    Wikipedia
    Wikipedia

  2. Arrowhead Pharmaceuticals

    World Rank (Aug-2026)
    1,882
    Market Cap (Aug-2026)
    12.238 Billion USD
    World Rank (Jan-05-2024)
    3,718
    Market Cap (Jan-05-2024)
    3.710 Billion USD
    World Rank (Jul-30-2023)
    3,705
    Market Cap (Jul-30-2023)
    3.755 Billion USD
    World Rank (Dec-25-2022)
    3,059
    Market Cap (Dec-25-2022)
    4.359 Billion USD
    World Rank (Jan-07-2022)
    2,778
    Market Cap (Jan-07-2022)
    6.16 Billion USD
    Annual Revenue in USD
    829 Million USD
    Annual Operating Income in USD
    98 Million USD
    Annual Net Income in USD
    -2 Million USD
    Annual Results for Period Ending
    For year ending September-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Bio-pharmaceutical company with headquarters is in California, USA.

    Company Website
    ARROWHEAD PHARMACEUTICALS INC
    Wikipedia
    Wikipedia

  3. Bio-Techne Corporation

    World Rank (Aug-2026)
    1,999
    Market Cap (Aug-2026)
    11.336 Billion USD
    World Rank (Jan-05-2024)
    1,474
    Market Cap (Jan-05-2024)
    11.453 Billion USD
    World Rank (Jul-30-2023)
    1,331
    Market Cap (Jul-30-2023)
    13.192 Billion USD
    World Rank (Dec-25-2022)
    1,229
    Market Cap (Dec-25-2022)
    12.986 Billion USD
    World Rank (Jan-07-2022)
    1,244
    Market Cap (Jan-07-2022)
    16.32 Billion USD
    Annual Revenue in USD
    1,215 Million USD
    Annual Operating Income in USD
    252 Million USD
    Annual Net Income in USD
    182 Million USD
    Annual Results for Period Ending
    For year ending June-2026
    Headquarters Country
    USA
    CEO
    Charles R. Kummeth
    Stock Category
    S&P 500
    Yahoo @ Nasdaq
    Company Profile

    BIO-TECHNE CORPORATION is Biotechnology company with headquarters is in Minnesota, USA. It develops, manufactures and sells instruments, for and services research, diagnostics.

    BIO-TECHNE CORPORATION total number of employees in 2022 was 3,000, a 15.38% increase from 2021.

    BIO-TECHNE CORPORATION annual revenue generated for period ending Jun-2022 was 1,105 Billion USD.

    BIO-TECHNE CORPORATION annual net income generated for period ending Jun-2022 was 271 Billion USD.

    Company Website
    Bio-Techne Corporation
    Wikipedia
    Wikipedia

  4. Axsome Therapeutics Inc

    World Rank (Aug-2026)
    2,058
    Market Cap (Aug-2026)
    10.883 Billion USD
    World Rank (Jan-05-2024)
    3,583
    Market Cap (Jan-05-2024)
    3.880 Billion USD
    World Rank (Jul-30-2023)
    6,099
    Market Cap (Jul-30-2023)
    1.818 Billion USD
    World Rank (Dec-25-2022)
    5,910
    Market Cap (Dec-25-2022)
    1.753 Billion USD
    Annual Revenue in USD
    638 Million USD
    Annual Operating Income in USD
    -167 Million USD
    Annual Net Income in USD
    -183 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile
    AXSOME THERAPEUTICS INC is a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The headquarters is in USA.
    Company Website
    AXSOME THERAPEUTICS INC

  5. Cytokinetics

    World Rank (Aug-2026)
    2,164
    Market Cap (Aug-2026)
    10.306 Billion USD
    World Rank (Jan-05-2024)
    1,870
    Market Cap (Jan-05-2024)
    8.652 Billion USD
    World Rank (Jul-30-2023)
    4,175
    Market Cap (Jul-30-2023)
    3.180 Billion USD
    World Rank (Dec-25-2022)
    3,096
    Market Cap (Dec-25-2022)
    4.314 Billion USD
    World Rank (Jan-07-2022)
    4,885
    Market Cap (Jan-07-2022)
    2.97 Billion USD
    Annual Revenue in USD
    88 Million USD
    Annual Operating Income in USD
    -612 Million USD
    Annual Net Income in USD
    -785 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile

    Cytokinetics is the Leading Muscle Biology Biopharmaceutical company. The headquarters is in USA.

    Facts About Company

    Cytokinetics Annual Total Revenue for year ending Dec-2022 was 94 million USD and and Net loss for year ending Dec-2022 was -388 million USD.

    Cytokinetics Annual Total Revenue for year ending Dec-2021 was 70 million USD and and Net loss for year ending Dec-2021 was -215 million USD.

    As on 2022, Cytokinetics has 409 employees.

    Company Website
    CYTOKINETICS
    Wikipedia
    Wikipedia

  6. Protagonist Therapeutics

    World Rank (Aug-2026)
    2,204
    Market Cap (Aug-2026)
    10.036 Billion USD
    World Rank (Jan-05-2024)
    7,332
    Market Cap (Jan-05-2024)
    1.316 Billion USD
    World Rank (Jul-30-2023)
    8,303
    Market Cap (Jul-30-2023)
    1.093 Billion USD
    World Rank (Dec-25-2022)
    12,464
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    7,030
    Market Cap (Jan-07-2022)
    1.66 Billion USD
    Annual Revenue in USD
    46 Million USD
    Annual Operating Income in USD
    -158 Million USD
    Annual Net Income in USD
    -130 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Stuttgart
    Company Profile

    Protagonist Therapeutics is a Clinical Stage Biopharmaceutical company with multiple peptide based new chemical entities in different stages of development. The headquarters is in USA.

    Facts About Company

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2022 was 26 million USD and and Net loss for year ending Dec-2022 was -127 million USD.

    Protagonist Therapeutics Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -125 million USD.

    As on 2022, Protagonist Therapeutics has 105 employees.

    Company Website
    PROTAGONIST THERAPEUTICS

  7. Nuvalent Inc.

    World Rank (Aug-2026)
    2,239
    Market Cap (Aug-2026)
    9.830 Billion USD
    World Rank (Jan-05-2024)
    3,133
    Market Cap (Jan-05-2024)
    4.610 Billion USD
    World Rank (Jul-30-2023)
    4,632
    Market Cap (Jul-30-2023)
    2.756 Billion USD
    World Rank (Dec-25-2022)
    6,273
    Market Cap (Dec-25-2022)
    1.605 Billion USD
    World Rank (Jan-07-2022)
    11,341
    Market Cap (Jan-07-2022)
    0.71 Billion USD
    Annual Operating Income in USD
    -414 Million USD
    Annual Net Income in USD
    -425 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Nuvalent, Inc., is a clinical stage biopharmaceutical company, and it develops therapies for patients with cancer.

    The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts, USA.

    Company Website
    NUVALENT, INC.

  8. Kymera Therapeutics Inc.

    World Rank (Aug-2026)
    2,250
    Market Cap (Aug-2026)
    9.761 Billion USD
    World Rank (Jan-05-2024)
    6,735
    Market Cap (Jan-05-2024)
    1.510 Billion USD
    World Rank (Jul-30-2023)
    7,820
    Market Cap (Jul-30-2023)
    1.208 Billion USD
    World Rank (Dec-25-2022)
    6,679
    Market Cap (Dec-25-2022)
    1.453 Billion USD
    World Rank (Jan-07-2022)
    5,018
    Market Cap (Jan-07-2022)
    2.86 Billion USD
    Annual Revenue in USD
    39 Million USD
    Annual Operating Income in USD
    -349 Million USD
    Annual Net Income in USD
    -311 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kymera is a Biopharmaceutical company. It is a developing novel protein degrader therapeutics to treat disease in powerful new ways which harness the body's natural protein degradation system to selectively degrade disease causing proteins with the goal of completely removing them from the body. The company annual revenue is 10.4 million USD and 67 employees as on 2019. The headquarters is in USA.
    Company Website
    KYMERA THERAPEUTICS, INC.

  9. Reata Pharmaceuticals

    World Rank (Aug-2026)
    2,443
    World Rank (Jan-05-2024)
    2,443
    World Rank (Jul-30-2023)
    2,443
    Market Cap (Jul-30-2023)
    6.278 Billion USD
    World Rank (Dec-25-2022)
    7,125
    Market Cap (Dec-25-2022)
    1.319 Billion USD
    World Rank (Jan-07-2022)
    9,134
    Market Cap (Jan-07-2022)
    1.05 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Net Income in USD
    -312 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Reata Pharmaceuticals is a Bio-pharmaceutical company with headquarters is in Texas, USA.

    Biogen acquired Reata Pharmaceuticals for 7.3 Billion USD in 2023.

    Company Website
    REATA PHARMACEUTICALS INC
    Wikipedia
    Wikipedia

  10. Vaxcyte Inc.

    World Rank (Aug-2026)
    2,456
    Market Cap (Aug-2026)
    8.641 Billion USD
    World Rank (Jan-05-2024)
    2,495
    Market Cap (Jan-05-2024)
    6.122 Billion USD
    World Rank (Jul-30-2023)
    3,324
    Market Cap (Jul-30-2023)
    4.376 Billion USD
    World Rank (Dec-25-2022)
    3,506
    Market Cap (Dec-25-2022)
    3.686 Billion USD
    World Rank (Jan-07-2022)
    8,241
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Annual Operating Income in USD
    -924 Million USD
    Annual Net Income in USD
    -767 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Vaxcyte is a Biotechnology company developing potentially superior and novel vaccines designed to prevent or treat the most common and deadly infectious diseases worldwide. It is having 43 employees as on 2019. The headquarters is in USA.

    Company Website
    VAXCYTE, INC.

Share